- 全部删除
您的购物车当前为空
Domatinostat (4SC202) 是一种 I 型 HDAC 抑制剂,能够抑制 HDAC1、HDAC2和 HDAC3 的活性,IC50值分别为 1.20 μM、1.12 μM 和 0.57 μM,同时能够抑制组蛋白赖氨酸特异性脱甲基酶1 的活性。

Domatinostat (4SC202) 是一种 I 型 HDAC 抑制剂,能够抑制 HDAC1、HDAC2和 HDAC3 的活性,IC50值分别为 1.20 μM、1.12 μM 和 0.57 μM,同时能够抑制组蛋白赖氨酸特异性脱甲基酶1 的活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 188 | In stock | |
| 5 mg | ¥ 568 | In stock | |
| 10 mg | ¥ 928 | In stock | |
| 25 mg | ¥ 1,730 | In stock | |
| 50 mg | ¥ 2,780 | In stock | |
| 100 mg | ¥ 3,990 | In stock | |
| 200 mg | ¥ 5,680 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 627 | In stock |
Domatinostat 相关产品
| 产品描述 | Domatinostat (4SC202) is a selective class I HDAC inhibitor with IC50 of 1.20 μM, 1.12 μM, and 0.57 μM for HDAC1, HDAC2, and HDAC3, respectively. Also displays inhibitory activity against Lysine specific demethylase 1 (LSD1). Phase 1. |
| 靶点活性 | HDAC3:0.57 μM, HDAC1:1.20 μM, HDAC10:21 μM, HDAC5:11.3 μM, HDAC2:1.12 μM, HDAC11:9.7 μM, HDAC9:50 μM |
| 体外活性 | In HeLa cells, 4SC-202 induces hyperacetylation of histone H3 with EC50 of 1.1 μM. 4SC-202 induces a G2/M cell cycle arrest by interfering with the normal development of the mitotic spindle and causing collapsed spindle apparatus and multiple nucleation centres. In addition, 4SC-202 shows a broad anti-proliferative activity towards human cancer cell lines with a mean IC50 of 0.7 μM. [1] |
| 体内活性 | In vivo, 4SC-202 has a high oral bioavailability, and shows high metabolic stability and a low plasma clearance. 4SC-202 (120 mg/kg p.o.) shows pronounced and robust anti-tumor activity in both A549 NSCLC xenograft and RKO27 colon carcinoma model. [1] |
| 别名 | 4SC-202 (free base), 4SC-202, 4SC202, 4SC 202 |
| 分子量 | 447.51 |
| 分子式 | C23H21N5O3S |
| CAS No. | 910462-43-0 |
| Smiles | Cn1cc(cn1)-c1ccc(cc1)S(=O)(=O)n1ccc(\C=C\C(=O)Nc2ccccc2N)c1 |
| 密度 | 1.34 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: < 1 mg/mL (insoluble or slightly soluble) DMSO: 82 mg/mL (183.24 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (7.37 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容